SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr Moncef Slaoui, PhD, to its Board of Directors. A highly accomplished leader in the biopharmaceutical industry...
Read More Details
Finally We wish PressBee provided you with enough information of ( Abzena Strengthens Board with Appointment of Biopharma Industry Leader, Dr Moncef Slaoui )
Also on site :
- This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
- In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook
- Walmart Is Selling an 'Absolutely Beautiful' $100 Jumpsuit for Just $20, and Shoppers Say It's 'Very Comfortable'